MAY 12, 2016 01:30 PM PDT

Canon BioMedical - Revealing New Genotyping Solutions

  • Senior Marketing Specialist, Canon BioMedical
      Brian McNally received his doctorate in Cell & Molecular Biology at University of Texas Southwestern Medical Center, where he focused on the transcriptional mechanisms governing polycystic kidney disease, renal cancer and development. His post-doctoral fellowship concentrated on the regulatory relationship between the proteasome and Toll-like receptor signaling at the University of Maryland Medical School in the Department of Immunology and Microbiology. Brian has fifteen years of practical experience at the laboratory bench, and his work has been published in peer-reviewed journals and presented at international conferences. In 2008, he transitioned to industry to commercialize new biomedical products including assays, reagents and software. Brian has been with Canon BioMedical since its inception last year. He is passionate about partnering with life scientists to develop the next wave of biomedical solutions.


    Canon BioMedical was established last year to develop innovative technologies and solutions that empower biomedical research and healthcare communities. Our mission is broad and encompassing, but what are the results that can help you right now? In the past year, we have continuously launched novel genotyping assays based on Canon’s expertise with high-resolution melting (HRM). 

    Are there DNA targets in your lab which are difficult to genotype using standard PCR or sequencing? HRM is an alternative solution that addresses focused genotyping needs. We have developed a library of common and unique targets for identifying single nucleotide polymorphisms (SNPs), small indels, and large deletions. Using any HRM-enabled thermocycler you can get conclusive results in a variety of research areas including cancer, neuroscience, and pharmacogenetics. 

    Join us to discuss how our Novallele™ assays can answer your difficult genotyping questions.

    Show Resources
    Loading Comments...